Comparison of the Stability, Efficacy, and Adverse Effect Profile of the Innovator 0.005% Latanoprost Ophthalmic Solution and a Novel Cyclodextrin-containing Formulation
Titel:
Comparison of the Stability, Efficacy, and Adverse Effect Profile of the Innovator 0.005% Latanoprost Ophthalmic Solution and a Novel Cyclodextrin-containing Formulation
Auteur:
Gonzalez, Jaime R. Baiza-Duran, Leopoldo Quintana-Hau, Juan Tornero-MontaƱo, Ruben Castaneda-Hernandez, Gilberto Ortiz, Mario Alarcon-Oceguera, Felipe Beltran-Loustaunau, Marco Cortez-Gastelum, Marco GarcidueƱas-Mejia, Jorge Gomez-Bastar, Pedro Jimenez-Roman, Jesus Korder-Ortega, Vincent Paczka-Zapata, Jose Torres-Segura, Marina Velasco-Gallegos, Gustavo